SARS-CoV-2 Lin. BQ.1.16; Omicron Var. (USA/NY-Wadsworth-22050865-01/2022) – CFHI

SARS-Related Coronavirus 2 Lineage BQ.1.16; Omicron Variant (Isolate: USA/NY-Wadsworth-22050865-01/2022) is an enveloped, positive-sense single-stranded RNA virus from the Coronaviridae family and the Betacoronaviridae genus. SARS-CoV-2 isolate USA/NY-Wadsworth-22050865-01/2022 was collected in October 2022 in New York, USA. Under the nomenclature system introduced by GISAID (Global Initiative on Sharing All Influenza Data), SARS-CoV-2, isolate USA/NY-Wadsworth- 22050865-01/2022 is assigned lineage BQ.1.16. The complete genome of USA/NY-Wadsworth-22050865-01/2022 has been sequenced (GISAID: EPI_ISL_15604461). Each frozen aliquot contains 1 mL of heat inactivated viral culture fluid. The pre-inactivation titer was determined from an infectious aliquot. Viral inactivation is verified after heat inactivation by the absence of viral growth in tissue culture-based infectivity assays.

Heat inactivated viral culture fluids are sold as consumable testing materials. The suitability and performance characteristics should be determined by your laboratory for each intended usage. These products are NOT intended for use in the manufacture or processing of injectable products subject to licensure under section 351 of the Public Health Service Act or for any other product intended for administration to humans.

For BSL-2 or BSL-3 compliant labs only / -20° C.
Product Insert.pdf

Material Safety Data Sheet.pdf